Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tyme Technologies
Biotech
Syros buys Tyme, securing $190M to extend cash runway into 2025
By merging with the floundering Tyme and tapping investors including Flagship, Syros has extended its cash runway out into 2025.
Nick Paul Taylor
Jul 5, 2022 9:40am
BeiGene bumps up Wang to financial chief—Chutes & Ladders
Apr 2, 2021 9:30am
Tyme hires acting CMO 4 months after new CEO takes the wheel
Apr 1, 2021 9:40am
Attacking pancreatic cancer by thwarting its survival strategies
Jun 22, 2020 9:35am
